MDMA plus therapy for PTSD – a study with a partner
Part of Mental health clinical trials.
This study tests whether MDMA, combined with a type of talk therapy called CBCT (cognitive behavioral conjoint therapy), is more effective than CBCT alone for treating PTSD. You and a close partner will both participate in therapy sessions and take MDMA together.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with PTSD
- You have a close friend or family member who can also take part in the study and attend all visits with you
- You live in Ontario, near the Greater Toronto Area (GTA)
- You are willing to stop taking psychiatric medications, herbal supplements, and other medicines during the study
- You are in good physical health and can safely take MDMA (no serious heart, liver, or other medical issues)
- You can commit to staying overnight at the study site twice after each full-day MDMA session, and not drive for 24 hours after taking MDMA
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether MDMA (the drug in ecstasy) combined with a type of talk therapy called massed exposure therapy can help treat PTSD. It may be an option if standard treatments haven't worked well enough.
This study tests whether MDMA (a medication) combined with therapy can help veterans with post-traumatic stress disorder (PTSD). MDMA may help people process difficult memories and emotions more effectively during therapy sessions.
This trial tests if MDMA (a drug that can help with therapy) along with talk therapy can help military members with PTSD. It is designed for active duty, National Guard, or Reserve service members who have had PTSD for at least six months.
This Phase 2 trial tests whether therapy assisted by MDMA can reduce symptoms of moderate to severe post-traumatic stress disorder (PTSD) in eligible veterans. It includes supervised therapy sessions and extra study visits with video recording to track changes over time.
This study tests whether MDMA, given in a controlled clinical setting, can reduce symptoms of PTSD and alcohol use disorder in veterans. It also combines the medication with structured therapy sessions to help you manage symptoms without relying on alcohol or other substances.
This Phase 2 study tests whether MDMA combined with structured therapy can reduce stress symptoms in people who have been exposed to major work-related stress in healthcare or emergency response. It’s designed to help participants during special “experimental” sessions plus regular therapy sessions without MDMA.
Hear when a new PTSD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.